Juan Pablo Torres, MD, PhD, is the director of innovation at the University of Chile in Santiago, Chile. From 2006 to 2019, he worked as a consultant in the Pulmonary Department at the University of Navarra in Pamplona, Spain, where he also obtained a doctorate degree in medicine. He is an accomplished clinical researcher, who was a principal investigator of the International Lung Cancer Action Program (I-ELCAP) and the national delegate for Spain at the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines Committee. His main clinical and research interests are COPD and lung cancer screening. Dr Torres graduated as a medical doctor from the University of the Republic in Montevideo, Uruguay, in 1991. He completed an internal medicine residency at the University of Miami and a pulmonary and critical care fellowship at Tufts University in Boston, MA.

Moderator of 6 Sessions

Session Type
Industry Sponsored Symposium
Date
Sun, 20.02.2022
Session Time
04:30 PM - 06:00 PM
Room
Sala A
Session Description
COVID-19 and Vaccination in Children and Adolescents: From Bench to Exam Room - Symposium Supported by PfizerSession Description:Join us as we explore the benefits and risks of vaccination in children and adolescents. This symposium includes expert discussion on:•Burden of SARS-CoV-2•Clinical Trial Data for BNT162b2•Benefits and risks of vaccinating
Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
04:30 PM - 06:00 PM
Room
Sala B
Session Description
The introduction and use of acellular pertussis combination vaccines – real-world experiences - Symposium Supported by SanofiSession Description: Young infants are especially vulnerable to infections, with potentially serious morbidity and mortality throughout the world. Respiratory infections caused by Bordetella pertussis remain prevalent worldwide, with an estimated over 24 million pertussis cases per year. Vaccines to protect against pertussis have been available for several decades. Continued developments have been seen over time with the introduction of combined formulations and a switch from whole-cell to acellular vaccines. Today, combined acellular vaccines are commonly used in clinical practice, showing fewer adverse events than their whole-cell counterparts and combined formulations offering logistical benefits. Despite availability of these vaccines to provide the opportunity to protect vulnerable populations, vaccine coverage rates remain suboptimal and actually dropped in recent years in several countries. This problem has been further exacerbated by the COVID-19 pandemic. The expert panel will describe country-specific learnings and experiences associated with the introduction and use of acellular pertussis combination vaccines and will present the implications on real-world clinical practice. There will be a discussion of important learnings relevant to all attendees, with the goal of achieving equitable access to vaccines worldwide.
Session Type
WSPID Symposium
Date
Wed, 23.02.2022
Session Time
03:00 PM - 04:00 PM
Room
Sala C
Session Icon
Pre-Recorded with Live Q&A
Session Type
WSPID Symposium
Date
Thu, 24.02.2022
Session Time
03:15 PM - 04:25 PM
Room
Sala A
Session Icon
Pre-Recorded with Live Q&A
Session Type
WSPID Symposium
Date
Thu, 24.02.2022
Session Time
04:30 PM - 05:30 PM
Room
Sala B
Session Icon
Pre-Recorded with Live Q&A

Presenter of 6 Presentations

Conclusions

Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
04:30 PM - 06:00 PM
Room
Sala B
Lecture Time
05:50 PM - 05:55 PM

Welcome and introduction

Session Type
Industry Sponsored Symposium
Date
Sun, 20.02.2022
Session Time
04:30 PM - 06:00 PM
Room
Sala A
Lecture Time
04:30 PM - 04:35 PM

Introduction

Session Type
Interactive Symposium
Date
Wed, 23.02.2022
Session Time
09:45 AM - 10:45 AM
Room
Sala B
Session Icon
Live Session
Lecture Time
09:45 AM - 09:47 AM

Faculty Panel Discussion and Q&A Session

Session Type
Industry Sponsored Symposium
Date
Sun, 20.02.2022
Session Time
04:30 PM - 06:00 PM
Room
Sala A
Lecture Time
05:40 PM - 06:00 PM

Introduction of the expert panel and topics

Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
04:30 PM - 06:00 PM
Room
Sala B
Lecture Time
04:30 PM - 04:35 PM

Q&A

Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
04:30 PM - 06:00 PM
Room
Sala B
Lecture Time
05:40 PM - 05:50 PM